Effect of Pro Re Nata Regimen with Anti-VEGF on Type 3 Macular Neovascularization: Long-Term Outcomes

• Published in: Ophthalmic research Vol. 67; no. 1; pp. 282 - 291
• Main Authors: Toto, Lisa, Viggiano, Pasquale, Quarta, Alberto, Grassi, Mariaoliva, De Nicola, Chiara, Aloia, Raffaella, D'Aloisio, Rossella, Boscia, Giacomo, Boscia, Francesco, Porreca, Annamaria, Di Nicola, Marta, Savastano, Maria Cristina, Mastropasqua, Rodolfo
• Format: Journal Article
• Language: English
• Published: Basel, Switzerland 15.04.2024
• Subjects: Aged; Aged, 80 and over; Angiogenesis Inhibitors - administration & dosage; Bevacizumab - administration & dosage; Female; Fluorescein Angiography - methods; Follow-Up Studies; Fundus Oculi; Humans; Intravitreal Injections; Macula Lutea - pathology; Male; Middle Aged; Ranibizumab - administration & dosage; Research Article; Retrospective Studies; Time Factors; Tomography, Optical Coherence - methods; Treatment Outcome; Vascular Endothelial Growth Factor A - antagonists & inhibitors; Visual Acuity; Wet Macular Degeneration - diagnosis; Wet Macular Degeneration - drug therapy; Wet Macular Degeneration - physiopathology; Type 3 MNV; Pro Re Nata regimen; Macular atrophy
• ISSN: 0030-3747; 1423-0259; 1423-0259
• DOI: 10.1159/000538441

Abstract Introduction: The purpose of this study was to investigate long-term outcomes of intravitreal injections (IVI) of antivascular endothelial growth factor (VEGF) in neovascular age-related macular degeneration (nAMD) with type 3 macular neovascularization (MNV). Methods: This retrospective st...